Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines

Zhong,Zhiwei; Zhou,Fan; Wang,Dong; Wu,Mingming; Zhou,Weimin; Zou,Yeqing; Li,Jie; Wu,Linquan; Yin,Xiangbao

doi:10.3892/or.2018.6760

Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines

Authors:
- Zhiwei Zhong
- Fan Zhou
- Dong Wang
- Mingming Wu
- Weimin Zhou
- Yeqing Zou
- Jie Li
- Linquan Wu
- Xiangbao Yin
View Affiliations

Affiliations: Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Central Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: October 2, 2018 https://doi.org/10.3892/or.2018.6760
Pages: 3852-3860

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear. The purpose of the present study was to investigate the expression and functional significance of KLF9 in vitro, by assessing the expression of KLF9 in pancreatic cancer tissue samples and its association with the total survival of patients and clinicopathological data. The levels of KLF9 expression in adjacent tissues and pancreatic cancer tissues were detected using immunohistochemistry. Using western blot analyses, we assessed KLF9 expression in human pancreatic cancer cell lines. Using flow cytometric analysis and CCK-8, we evaluated the effects of KLF9 expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells. Its effects on migration and cell invasion were detected by performing Transwell assay. By conducting western blot analyses, we evaluated the expression of relative target proteins (involved in invasion, migration, apoptosis, and cell cycle distribution. Our results revealed that in both tissue samples and cell lines (particularly in BxPC-3 and PANC-1 cells) of pancreatic cancer, KLF9 exhibited relatively lower expression. In addition, low KLF9 expression was related to the differentiation (P<0.001) and depth of vascular invasion (P=0.016) and was associated with a poor overall survival rate. In PANC-1 and BxPC-3 cells, KLF9 overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the S phase, and inhibited the migration and invasion of tumor cells. KLF9 overexpression downregulated MMP-9, MMP-2 Bcl-2, N-cadherin and cyclin B, and upregulated the levels of E-cadherin, Bax, p53, CDK4 and cyclin D1. On the whole, our findings indicated that KLF9 exhibited low expression in pancreatic cancer, and upregulation of KLF9 may inhibit the progression of pancreatic cancer. KLF9 may have potential diagnostic and therapeutic values in this type of cancer.

View Figures

View References

1	Yang Y, Yan S, Tian H and Bao Y: Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies. Medicine (Baltimore). 97:e99942018. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
3	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
4	German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL and Yin D: Accuracy of Cancer Mortality Study Group: The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 35:126–131. 2011. View Article : Google Scholar : PubMed/NCBI
5	Limame R, de Beeck Op K, Lardon F, De Wever O and Pauwels P: Krüppel-like factors in cancer progression: Three fingers on the steering wheel. Oncotarget. 5:29–48. 2014. View Article : Google Scholar : PubMed/NCBI
6	Heard ME, Simmons CD, Simmen FA and Simmen RC: Krüppel-like factor 9 deficiency in uterine endometrial cells promotes ectopic lesion establishment associated with activated notch and hedgehog signaling in a mouse model of endometriosis. Endocrinology. 155:1532–1546. 2014. View Article : Google Scholar : PubMed/NCBI
7	Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, Daigo K, Sakakibara I, Okamura M, Harigae H, et al: Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol. 28:3917–3931. 2008. View Article : Google Scholar : PubMed/NCBI
8	Bieker JJ: Krüppel-like factors: Three fingers in many pies. J Biol Chem. 276:34355–34358. 2001. View Article : Google Scholar : PubMed/NCBI
9	Tetreault MP, Yang Y and Katz JP: Krüppel-like factors in cancer. Nat Rev Cancer. 13:701–713. 2013. View Article : Google Scholar : PubMed/NCBI
10	Yori JL, Johnson E, Zhou G, Jain MK and Keri RA: Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem. 285:16854–16863. 2010. View Article : Google Scholar : PubMed/NCBI
11	Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WP and Keri RA: Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia. 13:601–610. 2011. View Article : Google Scholar : PubMed/NCBI
12	Qiao F, Yao F, Chen L, Lu C, Ni Y, Fang W and Jin H: Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling. Mol Carcinog. 55:280–291. 2016. View Article : Google Scholar : PubMed/NCBI
13	Kang L, Lü B, Xu J, Hu H and Lai M: Downregulation of Krüppel-like factor 9 in human colorectal cancer. Pathol Int. 58:334–338. 2008. View Article : Google Scholar : PubMed/NCBI
14	Simmen FA, Su Y, Xiao R, Zeng Z and Simmen RC: The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reprod Biol Endocrinol. 6:412008. View Article : Google Scholar : PubMed/NCBI
15	Pabona JM, Velarde MC, Zeng Z, Simmen FA and Simmen RC: Nuclear receptor co-regulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus. J Endocrinol. 200:63–73. 2009. View Article : Google Scholar : PubMed/NCBI
16	Pabona JM, Simmen FA, Nikiforov MA, Zhuang D, Shankar K, Velarde MC, Zelenko Z, Giudice LC and Simmen RC: Krüppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: Implications for the pathogenesis of endometriosis. J Clin Endocrinol Metab. 97:E376–E392. 2012. View Article : Google Scholar : PubMed/NCBI
17	Fu DZ, Cheng Y, He H, Liu HY and Liu YF: The fate of Krüppel-like factor 9-positive hepatic carcinoma cells may be determined by the programmed cell death protein 5. Int J Oncol. 44:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
18	Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia S, Wang Y, Liu Y and Shi G: KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells. Prostate. 74:946–958. 2014. View Article : Google Scholar : PubMed/NCBI
19	Huang Y, Ju B, Tian J, Liu F, Yu H, Xiao H, Liu X, Liu W, Yao Z and Hao Q: Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening. Oncol Rep. 31:1235–1248. 2014. View Article : Google Scholar : PubMed/NCBI
20	Ying M, Tilghman J, Wei Y, Guerrero-Cazares H, Quinones-Hinojosa A, Ji H and Laterra J: Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition. J Biol Chem. 289:32742–32756. 2014. View Article : Google Scholar : PubMed/NCBI
21	Yang M, Ke NW, Zeng L, Zhang Y, Tan CL, Zhang H, Mai G, Tian BL and Liu XB: Survival analyses for patients with surgically resected pancreatic neuroendocrine tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems. Medicine (Baltimore). 94:e21562015. View Article : Google Scholar : PubMed/NCBI
22	Kamarajah SK, Burns WR, Frankel TL, Cho CS and Nathan H: Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) analysis. Ann Surg Oncol. 24:2023–2030. 2017. View Article : Google Scholar : PubMed/NCBI
23	Warner SL, Stephens BJ, Nwokenkwo S, Hostetter G, Sugeng A, Hidalgo M, Trent JM, Han H and Von Hoff DD: Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res. 15:6519–6528. 2009. View Article : Google Scholar : PubMed/NCBI
24	Frič P, Šedo A, Škrha J, Bušek P, Laclav M, Škrha P and Zavoral M: Early detection of sporadic pancreatic cancer: Time for change. Eur J Gastroenterol Hepatol. 29:885–891. 2017. View Article : Google Scholar : PubMed/NCBI
25	Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI
26	Sieber O, Heinimann K and Tomlinson I: Genomic stability and tumorigenesis. Semin Cancer Biol. 15:61–66. 2005. View Article : Google Scholar : PubMed/NCBI
27	Kang L and Lai MD: BTEB/KLF9 and its transcriptional regulation. Yi Chuan. 29:515–522. 2007.(In Chinese). View Article : Google Scholar : PubMed/NCBI
28	Lu XJ, Shi Y, Chen JL and Ma S: Krüppel-like factors in hepatocellular carcinoma. Tumour Biol. 36:533–541. 2015. View Article : Google Scholar : PubMed/NCBI
29	Sun J, Wang B and Liu Y, Zhang L, Ma A, Yang Z, Ji Y and Liu Y: Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression. Cancer Lett. 355:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
30	Limame R, de Beeck KO, Van Laere S, Croes L, De Wilde A, Dirix L, Van Camp G, Peeters M, De Wever O, Lardon F, et al: Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer. Oncoscience. 1:69–81. 2013.PubMed/NCBI
31	Tang H, Wei P, Chang P, Li Y, Yan D, Liu C, Hassan M and Li D: Genetic polymorphisms associated with pancreatic cancer survival: A genome-wide association study. Int J Cancer. 141:678–686. 2017. View Article : Google Scholar : PubMed/NCBI
32	Brown AR, Simmen RC, Raj VR, Van TT, MacLeod SL and Simmen FA: Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis. 36:946–955. 2015. View Article : Google Scholar : PubMed/NCBI
33	Bogachek MV, De Andrade JP and Weigel RJ: Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors. Cancer Res. 75:11–15. 2015. View Article : Google Scholar : PubMed/NCBI
34	Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
35	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
36	Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S and Laterra J: Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells. 29:20–31. 2011. View Article : Google Scholar : PubMed/NCBI